Dopamine-receptor blocking agent-associated akathisia: a summary of current understanding and proposal for a rational approach to treatment
Dopamine-receptor blocking agent-associated akathisia (DRBA-A) is an adverse effect that can significantly limit the use of these important medications for the treatment of a variety of psychiatric diseases, yet there is no unifying theory regarding its pathophysiology. This knowledge gap limits cli...
Saved in:
Main Authors: | Shaina Musco (Author), Vivian McAllister (Author), Ian Caudle (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acetaminophen improves tardive akathisia induced by dopamine D2 receptor antagonists
by: Koki Nagaoka, et al.
Published: (2023) -
Paroxetine Induced Akathisia: Necessity for Rational Use
by: Maryam Mousavi, et al.
Published: (2019) -
Metoclopramide-induced akathisia
by: Gaurav Chauhan, et al.
Published: (2012) -
Tardive akathisia related to the anti-hypertensive agent Sevikar-a case report
by: Men-Ting Hsieh, et al.
Published: (2017) -
Dopamine Receptor Availability in ADHD
by: J Gordon Millichap
Published: (2002)